BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26611598)

  • 21. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
    Foust KD; Flotte TR; Reier PJ; Mandel RJ
    Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
    Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
    Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.
    Horita Y; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Neurosci Res; 2006 Nov; 84(7):1495-504. PubMed ID: 16998918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
    Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport.
    Lu YY; Wang LJ; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    Neurosci Res; 2003 Jan; 45(1):33-40. PubMed ID: 12507722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury.
    Wei GJ; Zheng KW; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Li PF; Dong DM
    Cell Physiol Biochem; 2018; 47(1):129-139. PubMed ID: 29763918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene transfer for neuroprotection in animal models of Parkinson's disease and amyotrophic lateral sclerosis.
    Bohn MC; Connor B; Kozlowski DA; Mohajeri MH
    Novartis Found Symp; 2000; 231():70-89; discussion 89-93. PubMed ID: 11131547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating congenital megacolon by transplanting GDNF and GFRα-1 double genetically modified rat bone marrow mesenchymal stem cells.
    Zhou CB; Peng CH; Pang WB; Zhang D; Chen YJ
    Genet Mol Res; 2015 Aug; 14(3):9441-51. PubMed ID: 26345878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
    Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Setoguchi Y; Abe K
    Apoptosis; 2002 Aug; 7(4):329-34. PubMed ID: 12101392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.
    Islamov RR; Izmailov AA; Sokolov ME; Fadeev PO; Bashirov FV; Eremeev AA; Shaymardanova GF; Shmarov MM; Naroditskiy BS; Chelyshev YA; Lavrov IA; Palotás A
    Brain Res Bull; 2017 Jun; 132():44-52. PubMed ID: 28529158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evidence for impaired neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis (hSOD1(G93A)).
    Boucherie C; Caumont AS; Maloteaux JM; Hermans E
    Exp Neurol; 2008 Aug; 212(2):557-61. PubMed ID: 18539273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis].
    Abe K; Manabe Y; Murakami T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1160-1. PubMed ID: 12235826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo gene electroporation of glial cell line-derived neurotrophic factor (GDNF) into skeletal muscle of SOD1 mutant mice.
    Yamamoto M; Kobayashi Y; Li M; Niwa H; Mitsuma N; Ito Y; Muramatsu T; Sobue G
    Neurochem Res; 2001 Nov; 26(11):1201-7. PubMed ID: 11874201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy.
    Serra J; Alves CPA; Brito L; Monteiro GA; Cabral JMS; Prazeres DMF; da Silva CL
    Hum Gene Ther; 2019 Mar; 30(3):316-329. PubMed ID: 30200778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells.
    Nicaise C; Mitrecic D; Pochet R
    Neuropathol Appl Neurobiol; 2011 Feb; 37(2):179-88. PubMed ID: 20846186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.